Pacific Biosciences of California PACB Return on equity

Return on equity at other companies

IlluminaILMN

32.4%-35.7pp

Quanterix CorporationQTRX

-46.5%-576pp

RevvityRVTY

3.2%-0.5pp

Twist Bioscience CorporationTWST

-18.2%-6.3pp

Agilent TechnologiesA

21.3%+2.4pp

Rapid Micro BiosystemsRPID

-141.6%-501pp

FAQ

What is Pacific Biosciences of California's return on equity?

Pacific Biosciences of California (PACB) reported return on equity of -273.6% in Q1 2026.

How has Pacific Biosciences of California's return on equity changed year-over-year?

Pacific Biosciences of California's return on equity decreased by 53.5% year-over-year, from -178.3% to -273.6%.

What is the long-term trend for Pacific Biosciences of California's return on equity?

Over 5 years (2020 to 2025), Pacific Biosciences of California's return on equity has grown at a 69.9% compound annual growth rate (CAGR), from 15.1% to -213.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.